The Story Unfolds
BENSALEM, Pa., Sept. 24, 2024 /PRNewswire/ — The Law Offices of Howard G. Smith presents a unique opportunity for investors facing significant losses to take charge in a securities fraud class action lawsuit against Outset Medical, Inc. (“Outset Medical” or the “Company”) with the ticker symbol OM.
What Happened
Class Period: August 1, 2022 – August 7, 2024
Lead Plaintiff Deadline: October 28, 2024
During the specified class period, investors allegedly were kept in the dark about several crucial aspects. Firstly, that the Tablo products were being promoted for continuous renal replacement therapy, an FDA unapproved use. Secondly, the likelihood of Outset Medical needing to submit another 510(k) application for Tablo products. Thirdly, the risk of sales suspension for Tablo products pending FDA nod for additional uses.
Moreover, it is claimed that Outset Medical was ill-prepared from a sales team and process standpoint for the expected boost in Tablo sales. Consequently, the company’s revenue growth projections may falter due to these inadequacies, rendering the previous positive statements by defendants about the firm’s operations misleading or unfounded.
A Call to Action
If you find yourself part of the affected class, you are not obligated to act now. You have the freedom to engage your chosen counsel or adopt a passive stance and still be counted as a member of this class action. For further insight into this legal matter or if you wish to clarify any queries regarding your involvement, connect with Howard G. Smith, Esquire, at Law Offices of Howard G. Smith through the mentioned contact details.
Final Notes
This announcement may constitute Attorney Advertising in specific jurisdictions as per relevant laws and ethical standards.
For More Information
If you need additional details on the original content, feel free to visit here.
SOURCE Law Offices of Howard G. Smith
